Number of employees
4
Annual revenue
$50000
Cellular Engineering Technologies (CET) is an emerging biotechnology company in tissue engineering focused on developing novel technologies to expedite the drug discovery and screening processes. In addition, CET conducts research on non-embryonic stem cells with the ultimate goal of treating human disease. CET’s business focuses on three major themes: (1) stem cell research, (2) bioassay development and (3) drug discovery.